SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448 | -32.4% | 112,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $663 | +90.0% | 112,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $349 | -18.1% | 112,300 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $426 | -99.9% | 112,300 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $633,000 | -9.8% | 112,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $702,000 | -23.3% | 112,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $915,000 | -41.8% | 112,300 | +10.0% | 0.00% | -50.0% |
| Q4 2021 | $1,571,000 | +338.8% | 102,100 | +515.1% | 0.00% | +300.0% |
| Q3 2021 | $358,000 | +1134.5% | 16,600 | +937.5% | 0.00% | – |
| Q2 2021 | $29,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |